These Ab receptor-modified (ARMed) CAR T cells produced functional PD1 minibodies in vitro and demonstrated anti-tumor activity in vivo in a GBM xenograft model using NOD-Scid gammaC-null (NSG) mice. This evidence concerns the gene PDCD1 and neoplasm.